Recommendations for standards regarding preclinical neuroprotective and restorative drug development

被引:966
作者
Feinklestein, SP [1 ]
Fisher, M [1 ]
Furland, AJ [1 ]
Goldstein, LB [1 ]
Gorelick, PB [1 ]
Kaste, M [1 ]
Lees, KR [1 ]
Traystman, RJ [1 ]
Albers, GW [1 ]
Anwer, UE [1 ]
Ashwood, T [1 ]
Barone, FC [1 ]
Basta, SL [1 ]
Bogousslavsky, J [1 ]
Buchan, AM [1 ]
Cady, WJ [1 ]
Chan, PH [1 ]
Clemens, JA [1 ]
Cox, BF [1 ]
Craddock, RE [1 ]
Cramer, SC [1 ]
del Zoppo, GJ [1 ]
Dielrich, WD [1 ]
Elliott, P [1 ]
Faden, AI [1 ]
Feuerstein, GZ [1 ]
Ginsberg, MD [1 ]
Gold, M [1 ]
Greene, WL [1 ]
Hall, ED [1 ]
Hsu, CY [1 ]
Hunter, AJ [1 ]
Lai, M [1 ]
Lesko, LM [1 ]
Levy, DE [1 ]
Li, FH [1 ]
Locke, KW [1 ]
Lodge, D [1 ]
Lowe, D [1 ]
Marcoux, FW [1 ]
McCulloch, J [1 ]
McDermott, J [1 ]
Meibach, R [1 ]
Messersmith, EK [1 ]
Moseley, M [1 ]
Moskowitz, MA [1 ]
Mueller, AL [1 ]
Munro, F [1 ]
Nudo, RJ [1 ]
Oeda, J [1 ]
机构
[1] Univ Massachusetts, Mem Hlth Care, Worcester, MA 01605 USA
关键词
D O I
10.1161/01.STR.30.12.2752
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The plethora of failed clinical trials with neuroprotective drugs for acute ischemic stroke have raised justifiable concerns about how best to proceed for the future development of such interventions. Preclinical testing of neuroprotective drugs is an important aspect of assessing their therapeutic potential, but guidelines concerning how to perform preclinical development of purported neuroprotective drugs for acute ischemic stroke are lacking. This conference of academicians and industry representatives was convened to suggest such guidelines for the preclinical evaluation of neuroprotective drugs and to recommend to potential clinical investigators the data they should review to reassure themselves that a particular neuroprotective drug has a reasonable chance to succeed in an appropriately designed clinical trial. Without rigorous, robust, and detailed preclinical evaluation, it is unlikely that novel neuroprotective drugs will prove to be effective when tested in large, time-consuming, and expensive clinical trials. Additionally, similar recommendations are provided for drugs with the potential to enhance recovery after acute ischemic stroke. a burgeoning new field with great potential but little currently available data. The suggestions contained in this document are meant to serve as overall guidelines that must be adapted to the individual characteristics related in this document are meant to serve as overall guidelines that must be adapted to the individual characteristics related to particular drugs and their preclinical and clinical development needs.
引用
收藏
页码:2752 / 2758
页数:7
相关论文
共 44 条
[1]   Gender-linked brain injury in experimental stroke [J].
Alkayed, NJ ;
Harukuni, I ;
Kimes, AS ;
London, ED ;
Traystman, RJ ;
Hurn, PD .
STROKE, 1998, 29 (01) :159-165
[2]  
*AM HEART ASS, 1999, HEART STROK STAT UPD
[3]   TREATMENT OF ACUTE ISCHEMIC STROKE - CHALLENGING THE CONCEPT OF A RIGID AND UNIVERSAL TIME WINDOW [J].
BARON, JC ;
VONKUMMER, R ;
DELZOPPO, GJ .
STROKE, 1995, 26 (12) :2219-2221
[4]   Polynitroxyl albumin reduces infarct size in transient focal cerebral ischemia in the rat:: Potential mechanisms studied by magnetic resonance imaging [J].
Beaulieu, C ;
Busch, E ;
Röther, J ;
de Crespigny, A ;
Hsia, CJC ;
Moseley, ME .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1998, 18 (09) :1022-1031
[5]   RELATIONSHIP BETWEEN CORTICAL EVOKED-POTENTIAL AND LOCAL CORTICAL BLOOD-FLOW FOLLOWING ACUTE MIDDLE CEREBRAL-ARTERY OCCLUSION IN BABOON [J].
BRANSTON, NM ;
SYMON, L ;
CROCKARD, HA ;
PASZTOR, E .
EXPERIMENTAL NEUROLOGY, 1974, 45 (02) :195-208
[6]   The Greater Cincinnati Northern Kentucky Stroke Study - Preliminary first-ever and total incidence rates of stroke among blacks [J].
Broderick, J ;
Brott, T ;
Kothari, R ;
Miller, R ;
Khoury, J ;
Pancioli, A ;
Gebel, J ;
Mills, D ;
Minneci, L ;
Shukla, R .
STROKE, 1998, 29 (02) :415-421
[7]   Role of oxidants in ischemic brain damage [J].
Chan, PH .
STROKE, 1996, 27 (06) :1124-1129
[8]   Long-lasting neuroprotective effect of postischemic hypothermia and treatment with an anti-inflammatory/antipyretic drug - Evidence for chronic encephalopathic processes following ischemia [J].
Coimbra, C ;
Drake, M ;
BorisMoller, F ;
Wieloch, T .
STROKE, 1996, 27 (09) :1578-1585
[9]   EXPERIMENTAL ACUTE THROMBOTIC STROKE IN BABOONS [J].
DELZOPPO, GJ ;
COPELAND, BR ;
HARKER, LA ;
WALTZ, TA ;
ZYROFF, J ;
HANSON, SR ;
BATTENBERG, E .
STROKE, 1986, 17 (06) :1254-1265
[10]  
DERYCK M, 1992, BRAIN RES, V573, P44